UPC_CFI_407/2025

COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF

Procedural & sub-applicationsEvidence & InspectionBrussels LDGenericCase ClosedSettled at: Pre-merits

2025-12-22WithdrawnwithdrawalWithdrawal (RoP265)
The Düsseldorf Local Division accepted the mutual withdrawal of Atlas Global Technologies' infringement action and Vantiva's counterclaim for revocation concerning EP 3 353 901, with the parties waiving a cost decision.
2025-11-12Procedural onlyevidenceApplication for an Order for inspection pursuant to RoP199
Review order by the Brussels Local Division following an ex parte order for preservation of evidence/inspection pursuant to Rule 197.3 RoP in Genentech/Roche v Organon proceedings. The court confirmed the inspection orders with modifications, set a deadline for expert reports, and set a 31-day (or 20 working day) term for initiating infringement proceedings after receipt of the experts' report.
2025-05-30outcomeName.otherevidenceApplication for preserving evidence pursuant to RoP192
The Brussels Local Division granted Genentech / Roche's ex parte applications for an order to preserve evidence (R. 192–198 RoP) and an order for inspection (R. 199 RoP) against Organon and Shanghai Henlius Biotech concerning EP 3 401 335 B1 (biological pharmaceutical patent). The orders were granted after an oral hearing on 23 May 2025. The order to preserve evidence required production of digital information; Organon NV and Organon Heist BV face a penalty of EUR 200,000 per hour for failure to cooperate. Costs are stayed pending the main proceedings.